Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Schott Pharma Schweiz AG operates a company patent portfolio in the Medical Devices & Mechanical Engineering technology area. The portfolio currently has 3 pending office actions. These actions are distributed among 3 distinct examiners and 3 distinct art units, showing a one to one ratio between the pending matters and the personnel or units assigned to them. This distribution suggests that the 3 pending office actions cover distinct technical aspects that require review by different specialized groups within the patent office.
The busiest examiner for the company is ACKUN, JACOB K. This examiner is currently managing 1 busiest examiner pending office action. Given that there are 3 pending office actions and 3 distinct examiners, each examiner, including ACKUN, JACOB K, is responsible for exactly 1 of the company's active prosecution matters. For a practitioner, this means that the company's current prosecution efforts are spread evenly across 3 distinct examiners and 3 distinct art units, with no single individual or unit handling a majority of the workload in the Medical Devices & Mechanical Engineering field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ACKUN, JACOB K | 1 | 57.1% | +3.3% |
| OSINSKI, BRADLEY JAMES | 1 | 78.5% | +10.9% |
| NGUYEN, ANDREW H | 1 | 75.2% | +42.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18307417 | CONTAINER WITH PLUNGER AND LOCKING ARRANGEMENT | NGUYEN, ANDREW H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18521236 | CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID, AS WELL AS A CANNULA ASSEMBLY AND CLOSURE SYSTEM FOR A CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID | OSINSKI, BRADLEY JAMES | — |
| 18307417 | CONTAINER WITH PLUNGER AND LOCKING ARRANGEMENT | NGUYEN, ANDREW H | — |
| Art Unit | Apps |
|---|---|
| 3736 | 1 |
| 3783 | 1 |
| 3741 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19172935 | ASSEMBLY FOR PHARMACEUTICAL CONTAINERS FOR REDUCING CONTACT BETWEEN CONTAINERS AND SIDEWALLS OF ASSEMBLY | ACKUN, JACOB K | 3736 | §103 | Non-Final OA | — | Pending | Apr 08, 2025 |
| 18521236 | CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID, AS WELL AS A CANNULA ASSEMBLY AND CLOSURE SYSTEM FOR A CONTAINER WHICH CAN BE PREFILLED OR IS PREFILLED WITH FLUID | OSINSKI, BRADLEY JAMES | 3783 | DP | Non-Final OA | — | Pending | Nov 28, 2023 |
| 18307417 | CONTAINER WITH PLUNGER AND LOCKING ARRANGEMENT | NGUYEN, ANDREW H | 3741 | §102§103 | Non-Final OA | — | Pending | Apr 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSchott Pharma Schweiz AG has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Jacob K Ackun has the most, with 1 of Schott Pharma Schweiz AG's pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
